Assay development & screening to discover small-molecule cancer probes or drugs (R01 — no clinical trials)
The NCI R01 supports discovery-stage projects to design and validate primary screening assays, implement high- or moderate-throughput screens (including virtual screening), and perform hit validation to identify small-molecule chemical probes or therapeutic leads targeting tumor cells or tumor-regulating immune cells. Applicants should focus on one or two stages with strong feasibility or prel…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support discovery research for the identification of small molecules that function to elucidate the biology of cancer as chemical probes or function as activators or inhibitors of cancer target(s) f…
Funding Source
Eligibility
- Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Required registratio…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers